SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004424
Filing Date
2024-01-31
Accepted
2024-01-31 09:15:36
Documents
17
Period of Report
2024-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48138
2 ex99-1.htm EX-99.1 14022
3 ex99-1_001.jpg GRAPHIC 4100
  Complete submission text file 0001493152-24-004424.txt   291084

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nrxs-20240125.xsd EX-101.SCH 3260
5 XBRL DEFINITION FILE nrxs-20240125_def.xml EX-101.DEF 26190
6 XBRL LABEL FILE nrxs-20240125_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE nrxs-20240125_pre.xml EX-101.PRE 24848
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5092
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 24580818
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)